Clinical Trials on Platelet Activation in Korea, Democratic People's Republic of
Total 89 results
-
Korea University Anam HospitalRecruitingPlatelet Activation | Hemodialysis Fistula ThrombosisKorea, Republic of
-
Bundang CHA HospitalWithdrawnShoulder Muscle Activation | Surface EmgKorea, Republic of
-
CHA UniversityEnrolling by invitationShoulder Muscle Activation | Surface EmgKorea, Republic of
-
SL VAXiGENSL BIGENUnknownBK Virus Infection | Cytomegalovirus Infections | Preventation of Cytomegalovirus Reactivation | Preventation of BK Virus ReactivationKorea, Republic of
-
Seoul National University HospitalCompletedPlatelet DysfunctionKorea, Republic of
-
Gyeongsang National University HospitalUnknownCoronary Artery Stenosis | Maximal Platelet Aggregation | Late Platelet Aggregation | High Post-Treatment Platelet ReactivityKorea, Republic of
-
Seoul National University HospitalCompleted
-
Inha University HospitalRecruitingNegative Symptoms in Schizophrenia | Behavioral Activation | Schizophrenia, Latent | Remote Medical ServiceKorea, Republic of
-
Konkuk University Medical CenterFoundation Medicine; Roche DiagnosticsRecruitingAdenocarcinoma of Lung | EGFR Activating MutationKorea, Republic of
-
Dong-Gun LeeEnrolling by invitationHBV | Hematopoietic Stem Cell Transplantation | Hepatitis B Reactivation | Antiviral DrugKorea, Republic of
-
Keimyung University Dongsan Medical CenterCompletedEndoscopic Submucosal Dissection | Platelet-rich PlasmaKorea, Republic of
-
Gyeongsang National University HospitalCompletedBleeding | Acute Coronary Syndrome | Platelet ThrombusKorea, Republic of
-
Samsung Medical CenterCompletedIdiopathic Thrombocytopenic PurpuraKorea, Republic of
-
Bristol-Myers SquibbRecruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of
-
Gyeongsang National University HospitalCompletedMyocardial Reperfusion Injury | Platelet Aggregation Inhibitors | Anti-inflammatory AgentKorea, Republic of
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Gyeongsang National University HospitalKorean Society of Interventional CardiologyCompletedCoronary Artery Disease | Stent Thrombosis | Clopidogrel, Poor Metabolism of | Platelet DysfunctionKorea, Republic of
-
Cooperative Study Group A for HematologyCompletedIdiopathic Thrombocytopenic PurpuraKorea, Republic of
-
Seoul National University HospitalRecruitingRelapsed/Refractory Immune ThrombocytopeniaKorea, Republic of
-
SK Plasma Co., Ltd.CompletedImmune ThrombocytopeniaKorea, Republic of
-
Seoul National University HospitalHallym University Medical CenterUnknownImmune Thrombocytopenia | Immune Thrombocytopenic Purpura | Helicobacter PyloriKorea, Republic of
-
Cooperative Study Group A for HematologyUnknownThrombocytopeniaKorea, Republic of
-
Cooperative Study Group A for HematologyUnknownImmune Thrombocytopenic PurpuraKorea, Republic of
-
SK Plasma Co., Ltd.CompletedImmune ThrombocytopeniaKorea, Republic of
-
Green Cross CorporationCompletedImmune ThrombocytopeniaKorea, Republic of
-
Yuhan CorporationCompletedEssential ThrombocythemiaKorea, Republic of
-
Ono Pharma USA IncTerminatedChemotherapy-Induced ThrombocytopeniaUnited States, Korea, Republic of, Russian Federation
-
Mashhad University of Medical SciencesCompletedThrombocytopenia | Chemotherapy | Severe Neutropenia | Blood Dyscrasia PatientsIran, Islamic Republic of
-
Isfahan University of Medical SciencesAdibviraCompletedITP | Croticosteroid TherapyIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedThrombocytopaeniaBelgium, Greece, Netherlands, Romania, China, Korea, Republic of, Tunisia, France, Hong Kong, Ireland, Peru, Poland
-
AryoGen Pharmed Co.CompletedFactor VII Deficiency | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Glanzmann's ThrombastheniaIran, Islamic Republic of
-
Novartis PharmaceuticalsActive, not recruitingImmune Thrombocytopenia (ITP) | Cold Agglutinin Disease (CAD)United States, Spain, Germany, Korea, Republic of, United Kingdom, Italy
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
UCB Biopharma SRLTerminatedPrimary Immune ThrombocytopeniaUnited States, Bulgaria, France, Georgia, Greece, Hungary, Italy, Japan, Korea, Republic of, Moldova, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine, United Kingdom
-
Alnylam PharmaceuticalsWithdrawnAtypical Hemolytic Uremic SyndromeSweden, Moldova, Republic of, Latvia, Lithuania, Estonia, Bosnia and Herzegovina, Canada, Georgia, Macedonia, The Former Yugoslav Republic of, Serbia
-
South Eastern Sydney Local Health DistrictGlaxoSmithKlineUnknownThrombocytopeniaSingapore, Korea, Republic of, Thailand, Turkey, Australia, Colombia, Kuwait, Malaysia, Taiwan, Uruguay
-
OctapharmaActive, not recruitingVon Willebrand DiseaseUnited States, Moldova, Republic of, Czechia, Germany, North Macedonia, Russian Federation, Ukraine
-
Oscotec Inc.CompletedImmune ThrombocytopeniaUnited States, Greece, Korea, Republic of, Poland, Spain
-
GlaxoSmithKlineCompletedThrombocytopaeniaSpain, Taiwan, Bulgaria, United States, Argentina, Russian Federation, Germany, Korea, Republic of, Austria, India, Italy, United Kingdom, Poland, Romania, Ukraine, Hungary, Peru, Czech Republic, Mexico
-
Novartis PharmaceuticalsCompletedAsian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MFPrimary Myelofibrosis (MF) | Post-Polycythemia Vera (PV) MF | Post-Essential Thrombocythemia (ET) MFTaiwan, Japan, Korea, Republic of, China
-
Telios Pharma, Inc.RecruitingMyelofibrosis | Indolent Systemic MastocytosisUnited States, Spain, Belgium, Australia, Taiwan, Germany, Poland, Korea, Republic of, Hungary, Brazil, Bulgaria, France, Italy
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicThailand, Korea, Republic of, United Kingdom, New Zealand, Germany, Greece, Hong Kong, Pakistan, Poland, Romania, Russian Federation, Slovenia, Taiwan
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicItaly, Germany, Hong Kong, Korea, Republic of, United States, Pakistan, Russian Federation, India, Czech Republic, Hungary, France
-
SyntaraParexelRecruitingMyelofibrosisTaiwan, Australia, Korea, Republic of, United States
-
Alexion Pharmaceuticals, Inc.RecruitingThrombotic MicroangiopathyUnited States, France, Israel, Italy, Japan, Korea, Republic of, Spain, United Kingdom, Germany
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Metastatic Lung Cancer | Antineoplastic Agents | Brain Metastases | Lung Neoplasm Malignant | EGFR... and other conditionsUnited States, Canada, Korea, Republic of, Japan, Taiwan
-
Novartis PharmaceuticalsRecruitingPrimary Immune Thrombocytopenia (ITP)Spain, Italy, France, Germany, China, Korea, Republic of, Czechia, Turkey, Malaysia, United States, Argentina, Australia, United Kingdom, Poland
-
Alexion Pharmaceuticals, Inc.CompletedAtypical Hemolytic Uremic Syndrome (aHUS)Italy, United States, Korea, Republic of, Spain, Germany, Belgium, United Kingdom
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
Merck Sharp & Dohme LLCRecruitingEssential ThrombocythemiaPoland, Israel, Australia, Hong Kong, Japan, New Zealand, Taiwan, Korea, Republic of, United States, Spain, Italy, Netherlands